Reduction of Low-Density Lipoprotein Cholesterol (LDL-C) With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study

Clinical trial NCT01375751 · COMPLETED

Trial details

NCT number: NCT01375751
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hypercholesterolemia, Familial

Start date: 2011-08-02
Primary completion: 2012-05-16
Enrollment: 168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.